Immunocytochemical evidence for interleukin-2 receptor regulation on rat anterior pituitary and adrenal cells

Acta Histochemica et Cytochemica

Volumn 29, Issue 3, 1996, Pages 255-260

  Tominaga, Tomoko ^a   Fukata, Junichi ^b   Fujimoto, Toyoshi ^a,d   Ogawa, Kazuo ^a,d   Diamanstein, Tibor ^c   Imura, Hiroo ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d GUNMA UNIVERSITY   (Japan)

Author keywords

Adrenal; Anterior pituitary; Immunocytochemistry; Interleukin 2 receptor

Indexed keywords

EID: 0030433077     PISSN: 00445991     EISSN: None     Source Type: Journal    
DOI: 10.1267/ahc.29.255     Document Type: Article

References (30)

1. Akahoshi, T, Oppenheim, J. J. and Matsushima, K.: Interleukin-1 stimulates its own receptor expression on human fibroblasts through the endogenous production of prostaglandin(s). J. Clin. Invest. 82; 1219-1224, 1988.
2. Artz, E., Stelzer, G., Renner, U., Lange, M., Muller, Q. A. and Stella, G. K.: Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell culture. J. Clin. Invest. 90; 1944-1951, 1992.
3. Batuman, O. A., Ferrers, A. P., Diaz, A., Berger, B. and Pomerantz, R. J.: Glucocorticoid-mediated inhibition of interleukin-2 receptor alpha and -beta subunit expression by human T cells. Immunopharmacology 27; 43-55, 1994.
4. Besedovsky, H. O. and Del Rey, A.: Immune-neuro-endocrine interaction: Facts and hypotheses. Endocrine. Rev. 17; 64-102, 1996.
5. Brown, S. L., Smith, L. R. and Blalock, J. E.: Interleukin 1 and interleukin 2 enhance proopio-melanocortin gene expression in pituitary cells. J. Immunol. 139; 3181-3183, 1987.
6. Cambronero, J. C., Rivas, F. J., Borrell, J. and Guaza, C.: Interleukin-2 induces corticotropin-releasing hormone release from superfused rat hypothalami: influence of glucocorticoids. Endocrinology 131; 677-683, 1992.
7. Chambrier, C., Mercatello, A., Tagnet, E., Cottet-Emard, J. M., Cohen, R., Blay, J. Y., Favrot, M., Philip, T. and Beylet, M.: Hormonal and metabolic effects of chronic interleukin-2 infusion in cancer patients. J. Biol. Response Mod. 9; 251-255, 1990.
8. Dcnicoff, K. D., Durkin, T. M., Lotze, M. T., Quinlan, P. E., Davis, C. L., Listwak, S. J., Rosenberg, S. A. and Rubinow, D. R.: The neuroendocrine effects of interleukin-2 treatment. J. Clin. Endocrinol. Metab. 69; 402-410, 1989.
9. Farrar, W. L.: Endorphin modulation of lymphokine activity. In: "Opioid Peptides in the Periphery," ed. by F. Fraioli, A. Isidori and M. Mazzetti, Elsevier, New York, 1984, pp. 159-165.
10. Fernandes-Ruiz, E., Rebollo, A., Nieto, M. A., Sanz, E., Somoza, C., Ramirez, F., Lopez-Rivas, A. and Silva, A.: IL-2 protects T cell hybrids from the cytolytic effect of glucocorticoids. J. Immunol. 143; 4146-4151, 1989.
11. Gillis, S., Crabtree, G. R. and Smith, A.: Glucocorticoid-induced inhibition of T cell growth factor production. J. Immunol. 123; 1624-1631, 1979.
12. Guo, H., Calkins, J. H., Sigel, M. M. and Lin, T.: Interleukin-2 is a potent inhibitor of Leydig cell steroidogenesis. Endocrinology 127; 1234-1239, 1990.
13. Imura, H., Fukata, J. and Mori, T.: Cytokines and endocrine function: an interaction between the immune and neuroendocrine system. Clin. Endocrinol. 35; 107-115, 1991.
14. Jankovic, D. L., Gibert, M., Baron, D., Ohara, J., Paul, W. E. and Theze, J.: Activation of IL-2 but not IL-4, up-regulates the expression of the p55 subunit of the IL-2 receptor on IL-2-, and IL-4-dependent T cell line. J. Immunol. 142; 3113-3120, 1989.
15. Karanth, S., McCann, S. M.: Anterior pituitary hormone control by interleukin-2. Proc. Natl. Acad. Sci. U.S.A. 88; 2961-2965, 1991.
16. Lissoni, P., Barni, S., Archili, C., Cattaneo, G., Rovelli, F., Conti, A., Maestroni, G. J. and Tancini, G.: Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the imuruno-therapy of cancer. Anticancer Res. 10; 753-758, 1990.
17. Lotze, M. T., Frana, L. W., Sharrow, S. O., Robb, R. J. and Rosenberg, S. A.: In vivo administration of purified human interleukin 2. J. Immunol. 134; 157-166, 1985.
18. Lubinski, J., Fong, T. C., Babbitt, J. T., Ransone, L., Yodoi, J. and Bloom, E. T.: Increased binding of IL-2 and increased IL-2 receptor mRNA synthesis are expressed by NK-Iike cell line in response to IL-1. J. Immunol. 140; 1903-1909, 1988.
19. Naito, Y., Fukata, J., Tominaga, T., Masui, Y., Hirai, Y., Murakami, N., Tamai, S., Mori, K. and Imura, H.: Adrenocorticotropic hormone-releasing activities of interleukins in a homologous in vivo system. Biochem. Biophys. Res. Comm. 164; 1262-1267, 1989.
20. Narumiya, S., Hirata, M., Nanba, T., Nikaido, T., Taniguchi, Y., Tagaya, Y., Okada, M., Mitsuya, H. and Yodoi, J.: Activation of interleukin-2 receptor gene by forskolin and cyclic AMP analogues. Biochem. Biophys. Res. Comm. 143; 753-760, 1987.
21. Osawa, H. and Diamanstein, T.: The characteristics of a monoclonal antibody that binds specifically to rat T lymphoblasts and inhibit IL2 receptor functions. J. Immunol. 30; 51-55, 1983.
22. Reed, J. C., Abidi, A. H., Alpers, J. D., Hoover, R. G., Robb, R. J. and Nowell, P. C.: Effects of cyclosporin A and dexamethasone on interleukin-2 receptor gene expression. J. Immunol. 137; 150-153, 1986.
23. Reem, G. H. and Yeh, N.: Interleukin 2 regulates expression of its receptor and synthesis of gamma Interferon by human T lymphocytes. Science 225; 429-430, 1984.
24. Shirakawa, F., Tanaka, Y., Eto, S., Suzuki, H., Yodoi, J. and Yamashita, U.: Effect of interleukin I on the expression of interleukin 2 receptor (Tac antigen) on human natural killar cells and natural killar-like cell line (YT cells). J. Immunol. 137; 551-556, 1986.
25. Smith, L. R., Brown, S. L. and Blalock, J. E.: Interleukin-2 induction of ACTH secretion: presence of an interleukin-2 receptor alpha-chain-like molecule on pituitary cells. J. Neuroimmunol. 2; 249-254, 1989.
26. Tanaka, K., Tilney, N. L., Stunkel, K. G., Hancock, W. W., Diamanstein, T. and Kupiec-Weglinski, J. W.: Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts. Proc. Natl. Acad. Sci. U.S.A. 87; 7375-7379, 1990.
27. Tominaga, T., Fukata, J., Nakai, Y. and Imura, H.: Prostaglandin-dependent in vitro stimulation of adrenocortical steroidogenesis by interleukins. Endocrinology 128; 526-531, 1990.
28. Trzeciak, W. H., Lettoux, J. G., Waterman, M. R. and Simpson, E. R.: Dexamethasone inhibits corticotropin-induced accumulation of CYP11A messenger RNAs in bovine adrenocortical cells. Mol. Endocrinol. 7; 206-213, 1993.
29. Umeuchi, M., Makino, T., Arisawa, M., Izumi, S., Saito, S. and Nozawa, S.: The effect of Interleukin-2 on the release of gonadotropin and prolactin in vivo and in vitro. Endocrine. J. 41; 547-551,1994.
30. Wilson, A., Corthesy, P., Reichenbach, P., MacDonald, H. R. and Nabholz, M.: Interleukin(IL)-1 and IL-2 control IL-2 receptor alpha and beta expression in immature thymocyte. Eur. J. Immunol. 24; 1729-1735,1994.